Adjuvant radiation therapy improves survival in stage IIIA (N2) non-small cell lung cancer with persistent N2 disease after neoadjuvant chemotherapy-Reference-Cited by-同舟云学术

Adjuvant radiation therapy improves survival in stage IIIA (N2) non-small cell lung cancer with persistent N2 disease after neoadjuvant chemotherapy

Published:2022-11 Issue: Volume:176 Page:234-238
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Komiya Takefumi,Takamori Shinkichi,Wilding Gregory

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference19 articles.

1. National Cancer Institute Surveillance, Epidemiology, and End Results Program. Annual report to the nation 2021: overall cancer statistics. https://seer.cancer.gov/report_to_nation/statistics.html [accessed on May 9, 2022].

2. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group;Pignon;J Clin Oncol,2008

3. Preoperative chemotherapy for non-small cell lung cancer: a systematic review and meta-analysis of individual participant data;NSCLC Meta-analysis Collaborative Group;Lancet,2014

4. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials;PORT Meta-analysis Trialists Group;Lancet,1998

5. Postoperative radiotherapy for Stage II or III non–small-cell lung cancer using the surveillance, epidemiology, and end results database;Lally;J Clin Oncol,2006

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the past, present, and future of postoperative radiotherapy for N2 stage non-small cell lung cancer;Radiation Oncology Journal;2023-09-30

2. Efficacy of immune checkpoint inhibitors in younger patients with non-small cell lung cancer;Journal of Cancer Research and Clinical Oncology;2023-07-21

3. Postoperative radiotherapy for ypN2 non-small cell lung cancer after neoadjuvant chemotherapy and surgery warrants further evaluation;Radiotherapy and Oncology;2022-12

4. Response to Bao et al;Radiotherapy and Oncology;2022-12